Opko Health, Inc. OPK

Company Overview

OPKO Health, Inc. is a diversified healthcare company operating across the biotechnology, diagnostics, and pharmaceutical industries. The company develops and commercializes diagnostics, laboratory services, and specialty pharmaceutical products, with activities spanning clinical testing, drug development, and biologics. OPKO’s business model combines recurring diagnostic service revenue with pharmaceutical product sales and licensing arrangements. Its primary revenue drivers have included diagnostic laboratory operations through BioReference Health, sales associated with pharmaceutical products and royalty arrangements, and collaborative agreements tied to drug development programs.

The company was founded in 1991 and later transformed under the leadership of Dr. Phillip Frost, who became chairman and a major shareholder following a series of acquisitions and restructuring initiatives during the late 2000s. OPKO expanded through acquisitions in diagnostics and biotechnology, including the acquisition of Bio-Reference Laboratories in 2015, which significantly increased its laboratory testing capabilities and physician network reach. The company has positioned itself as an integrated healthcare platform with exposure to both clinical services and therapeutics development, particularly in endocrinology, nephrology, and infectious disease diagnostics.